Apollo Cancer Checkup Ultra Female in Vijayawada

Apollo’s Cancer Checkup Ultra – Female is a package covering a wide range of tests for the early cancer screening of various cancers. It helps identify the potential cancer risks, creating room for an early intervention. The package is perfect for women to monitor their health as it involves a wide range of tests for early cancer detection using advanced technology. Usually, Apollo offers tests like haemograms, carcinoembryonic antigen tests (CEA), Alpha-fetoprotein (AFP), cancer antigen 19-9 (CA 19.9), cancer antigen 15-3 (CA 15.3), cancer antigen 125 (CA 125), beta-HCG (human chorionic gonadotropin), protein electrophoresis, urine cytology, serum thyroglobulin and calcitonin in the package. At times, so many tests may seem redundant as individual tests can be done. However, it is a misconception that this combined package of tests helps doctors with early cancer detection (if any) and the severity. Moreover, individual tests are more expensive and time-consuming than the package.

Which Tests Are Included in Cancer Checkup Ultra - Female?

The Cancer Checkup Ultra – Female includes a range of diagnostic tests that help detect potential cancer markers in the body.

• Haemogram: This is a complete blood count (CBC) with a set of 32 tests measuring the levels of RBC, WBC, platelets, haemoglobin and haematocrit in the bloodstream. Any disorder in these components indicates anaemia, infection or cancer.
• Carcinoembryonic antigen test (CEA): CEA (normal range is 0-2.5 ng/mL) is a protein, a type of tumour marker. A CEA test measures the amount of CEA present in the blood. This level is elevated significantly if there is colorectal cancer. However, it also remains elevated in breast, lung or pancreatic cancers.
• Alpha-Fetoprotein (AFP): This test measures the amount of a protein called AFP in blood, commonly used to detect liver cancer. A high level of AFP (normal range is 0-40 ng/mL for non-pregnant women) may indicate germ cell tumours of the ovaries or chronic liver disease.
• CA19.9: CA 19.9 (normal range 0-37 U/mL) is a type of antigen released by pancreatic cancer cells and works as a tumour marker. An elevated level of CA 19.9 may indicate the possibility of cancer of the pancreas, liver or gastrointestinal tract.
• CA 15.3: CA 15.3 (normal range is 30 U/mL or less) is a type of protein produced in the blood, mainly by cancerous cells and tumours. Hence, a high level indicates the possibility of cancer. The test is primarily done to monitor the progression of breast cancer or recurrence after treatment.
• CA125: This test measures the amount of CA125 (normal range is 35 U/mL or less) protein in the blood. It is a screening test for ovarian cancer and also helps to determine the treatment progress.
• BETA hCG: A beta-human chorionic gonadotropin (hCG) test helps to determine the level of hCG hormone in the blood, mainly produced by the placenta during pregnancy, but can also be produced by specific cancer cells. An elevation in beta hCG indicates the possibility of gestational trophoblastic disease or ovarian cancer. The test also helps to monitor the progress of treatment in cancer-affected patients.
• Protein Electrophoresis: This test measures different types and levels of protein in a woman’s blood, assisting the doctors to identify if there is any liver or kidney disease or cancer like multiple myeloma.
• Urine Cytology: It examines urine for the presence of any abnormal cells that can indicate bladder cancer, urinary tract infection or other abnormalities.
  Serum Thyroglobulin: This blood test mainly helps to detect if the thyroid cancer treatment has worked.
• Calcitonin: It is a hormone produced by the thyroid gland. An elevated level of calcitonin may indicate the possibility of C-cell hyperplasia leading to medullary thyroid cancer (a rare form of cancer).

Who Should Get Cancer Checkup Ultra-Female?

Any woman who wants to adopt a proactive and preventive approach towards health should undergo this cancer screening. However, some conditions which call for an immediate checkup are –

• Individuals menstrual irregularities or reproductive health concerns.
• Those with a prior history of cancer.
• Individuals with a family history of cancer.
• Those experiencing unexplained weight loss, fatigue or unusual bleeding.
• Individuals diagnosed with polycystic ovary syndrome (PCOS)

However, several other risk factors and symptoms may indicate the presence of cancer. Some such factors are –

• Lifestyle risk factors – If a woman is overweight, smokes, leads a sedentary lifestyle, and is experiencing symptoms like unusual bleeding, abnormal weight loss and fatigue, then she must book Apollo’s Cancer Checkup Ultra – Female package. Such symptoms indicate the possibility of cancer.
• Hormonal imbalance issues – If there is a history of PCOS or thyroid disorder, then getting Apollo’s Cancer Checkup Ultra – Female package becomes essential. It includes tests like serum thyroglobulin and calcitonin, which help to monitor thyroid health as the above-mentioned symptoms indicate the possibility of thyroid cancer.
• Age above 40 – If there is a family history of cancer and the patient’s age is above 40, then she must consider Apollo’s Cancer Checkup Ultra – Female package done at regular intervals. This is because aged women have the risk of developing cancers like ovarian, uterine or breast.
• High-risk professions – Certain professions (like chemical labs, factories, etc.) demand working in environments filled with harmful chemicals or carcinogens. Women having this kind of exposure must avail Apollo’s Cancer Checkup Ultra – Female package at regular intervals as they are at high risk of developing cancer.